China Isotope & Radiation Corp
HKEX:1763
EV/EBITDA
Enterprise Value to EBITDA
Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.
Market Cap | EV/EBITDA | ||||
---|---|---|---|---|---|
CN |
C
|
China Isotope & Radiation Corp
HKEX:1763
|
3.5B HKD | 1.9 | |
JP |
Hoya Corp
TSE:7741
|
6.4T JPY | 23.4 | ||
CH |
Alcon AG
SIX:ALC
|
35.7B CHF | 17.9 | ||
DK |
Coloplast A/S
CSE:COLO B
|
193.7B DKK | 26.1 | ||
US |
Align Technology Inc
NASDAQ:ALGN
|
23.2B USD | 27.8 | ||
US |
Cooper Companies Inc
NYSE:COO
|
17.8B USD | 22.4 | ||
KR |
H
|
HLB Inc
KOSDAQ:028300
|
14.2T KRW | -122.5 | |
CN |
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
56.8B CNY | 29.9 | ||
UK |
ConvaTec Group PLC
LSE:CTEC
|
5.3B GBP | 46.8 | ||
US |
DENTSPLY SIRONA Inc
NASDAQ:XRAY
|
6.4B USD | 12.3 | ||
CA |
B
|
Bausch + Lomb Corp
NYSE:BLCO
|
5.2B USD | 15.8 |
EV/EBITDA Forward Multiples
Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.